1. Accelerating anticancer drug development — opportunities and trade-offs. Issue 12 (December 2018) Authors: Nass, Sharyl; Rothenberg, Mace; Pentz, Rebecca; Hricak, Hedvig; Abernethy, Amy; Anderson, Kenneth; Gee, Amanda; Harvey, R.; Piantadosi, Steven; Bertagnolli, Monica; Schrag, Deborah; Schilsky, Richard Journal: Nature reviews Issue: Volume 15:Issue 12(2018) Page Start: 777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addendum: Low-value approvals and high prices might incentivize ineffective drug development. Issue 12 (December 2018) Authors: Prasad, Vinay; McCabe, Christopher; Mailankody, Sham Journal: Nature reviews Issue: Volume 15:Issue 12(2018) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AI to assess images. Issue 12 (December 2018) Authors: Romero, Diana Journal: Nature reviews Issue: Volume 15:Issue 12(2018) Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alternative splicing in prostate cancer. Issue 11 (November 2018) Authors: Paschalis, Alec; Sharp, Adam; Welti, Jonathan; Neeb, Antje; Raj, Ganesh; Luo, Jun; Plymate, Stephen; Bono, Johann. Journal: Nature reviews Issue: Volume 15:Issue 11(2018) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BCC identity switch breaks restraints of Hedgehog pathway inhibition. Issue 12 (December 2018) Authors: Killock, David Journal: Nature reviews Issue: Volume 15:Issue 12(2018) Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin. Issue 12 (December 2018) Authors: Husain, Nisreen; El-Serag, Hashem Journal: Nature reviews Issue: Volume 15:Issue 12(2018) Page Start: 728 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CtDNA predicts outcomes in DLBCL. Issue 11 (November 2018) Authors: Sidaway, Peter Journal: Nature reviews Issue: Volume 15:Issue 11(2018) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Economic sustainability of immune-checkpoint inhibitors: the looming threat. Issue 12 (December 2018) Authors: Verma, Vivek Journal: Nature reviews Issue: Volume 15:Issue 12(2018) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Eliminating MRD — FDA approval of blinatumomab for B-ALL in complete remission. Issue 12 (December 2018) Authors: Hilal, Talal; Prasad, Vinay Journal: Nature reviews Issue: Volume 15:Issue 12(2018) Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EMBRACing a new PARP inhibitor?. Issue 11 (November 2018) Authors: Romero, Diana Journal: Nature reviews Issue: Volume 15:Issue 11(2018) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗